Aim: HER2/neu protein has garnered a great deal of interest in the popular media. However, it has long been known among pathologists and oncologists for its potential role as a tumor and prognostic marker. This protein exists on the surface of epithelial cells and functions in the normal cell as a receptor for a cellular growth factor. Aim of the study: is to determine the association of HER-2/neu and p53 as well as hormonal receptor status with common pathologic parameters in invasive ductal carcinoma of the breast. Methods: Expression of HER-2/neu and p53 was examined by immunohistochemistry in samples of breast tissue from 50 patients with invasive ductal carcinoma and their significance for prognosis was analyzed. Results: There was a s...
INTRODUCTION: Oesophageal carcinomas are one of the most aggressive human malignancies which are ass...
BACKGROUND : Carcinoma of the breast has clinical heterogeneity with high morbidity and mortality. ...
Objective HER-2/neu is overexpressed in diverse human cancers. Studies suggest a role of this protei...
Aim: HER2/neu protein has garnered a great deal of interest in the popular media. However, it has lo...
Aims and background: Amplification/overexpression of HER-2/neu and inactivation of p53 may be reliab...
The purpose of this study was to determine if any relationship exists between Estrogen Receptor (ER)...
To investigate the association between tumour characteristics and HER-2/neu by immunohistochemistry ...
The nuclear phosphoprotein p53 is expressed in all normal cells and appears to function in cell cycl...
Breast cancer is a malignant tumor mostly disclosed in women. It has heterogeneous biological behavi...
Background: Overexpression of HER-2/neu is associated with up-regulation of vascular endothelial gro...
We investigated the clinicopathologic and oncoprotein expression characteristics of 11 pure mucinous...
Abstract Background Breast carcinoma is a disease with a tremendous heterogeneity in its clinical be...
Background: Carcinoma breast is the commonest malignancy of females all over the world and second le...
2. SUMMARY Author: Bc. Lenka Celbová Tutor: MUDr. Jiří Hochmann, CSc. Title of a work: HER-2/neu and...
Some woman have breast tumors with higher level of HER-2. HER-2 receptor is is a member of the epide...
INTRODUCTION: Oesophageal carcinomas are one of the most aggressive human malignancies which are ass...
BACKGROUND : Carcinoma of the breast has clinical heterogeneity with high morbidity and mortality. ...
Objective HER-2/neu is overexpressed in diverse human cancers. Studies suggest a role of this protei...
Aim: HER2/neu protein has garnered a great deal of interest in the popular media. However, it has lo...
Aims and background: Amplification/overexpression of HER-2/neu and inactivation of p53 may be reliab...
The purpose of this study was to determine if any relationship exists between Estrogen Receptor (ER)...
To investigate the association between tumour characteristics and HER-2/neu by immunohistochemistry ...
The nuclear phosphoprotein p53 is expressed in all normal cells and appears to function in cell cycl...
Breast cancer is a malignant tumor mostly disclosed in women. It has heterogeneous biological behavi...
Background: Overexpression of HER-2/neu is associated with up-regulation of vascular endothelial gro...
We investigated the clinicopathologic and oncoprotein expression characteristics of 11 pure mucinous...
Abstract Background Breast carcinoma is a disease with a tremendous heterogeneity in its clinical be...
Background: Carcinoma breast is the commonest malignancy of females all over the world and second le...
2. SUMMARY Author: Bc. Lenka Celbová Tutor: MUDr. Jiří Hochmann, CSc. Title of a work: HER-2/neu and...
Some woman have breast tumors with higher level of HER-2. HER-2 receptor is is a member of the epide...
INTRODUCTION: Oesophageal carcinomas are one of the most aggressive human malignancies which are ass...
BACKGROUND : Carcinoma of the breast has clinical heterogeneity with high morbidity and mortality. ...
Objective HER-2/neu is overexpressed in diverse human cancers. Studies suggest a role of this protei...